Correction: Structure-based design, optimization, and evaluation of potent stabilized peptide inhibitors disrupting MTDH and SND1 interaction (Journal of Medicinal Chemistry (2022) 65:18 (12188-12199) DOI: 10.1021/acs.jmedchem.2c00862)

Hailing Chen; Meimiao Zhan; Jianbo Liu; Zhihong Liu; Minhong Shen; Fenfang Yang; Yibin Kang; Feng Yin; Zigang Li

doi:10.1021/acs.jmedchem.3c00892

Correction: Structure-based design, optimization, and evaluation of potent stabilized peptide inhibitors disrupting MTDH and SND1 interaction (Journal of Medicinal Chemistry (2022) 65:18 (12188-12199) DOI: 10.1021/acs.jmedchem.2c00862)

Hailing Chen, Meimiao Zhan, Jianbo Liu, Zhihong Liu, Minhong Shen, Fenfang Yang, Yibin Kang, Feng Yin, Zigang Li

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Page 12198. Instead of The authors declare no competing financial interest , the following Note should be included: The authors declare the following competing financial interest(s): Y.K. is a founder and equity holder of Firebrand Therapeutics, Inc, which is developing inhibitors against MTDH/SND1. Received.

Original language	English (US)
Pages (from-to)	7668
Number of pages	1
Journal	Journal of Medicinal Chemistry
Volume	66
Issue number	11
DOIs	https://doi.org/10.1021/acs.jmedchem.3c00892
State	Published - Jun 8 2023

All Science Journal Classification (ASJC) codes

Molecular Medicine
Drug Discovery

Access to Document

10.1021/acs.jmedchem.3c00892

Fingerprint

Dive into the research topics of 'Correction: Structure-based design, optimization, and evaluation of potent stabilized peptide inhibitors disrupting MTDH and SND1 interaction (Journal of Medicinal Chemistry (2022) 65:18 (12188-12199) DOI: 10.1021/acs.jmedchem.2c00862)'. Together they form a unique fingerprint.

Cite this

Chen, H., Zhan, M., Liu, J., Liu, Z., Shen, M., Yang, F., Kang, Y., Yin, F., & Li, Z. (2023). Correction: Structure-based design, optimization, and evaluation of potent stabilized peptide inhibitors disrupting MTDH and SND1 interaction (Journal of Medicinal Chemistry (2022) 65:18 (12188-12199) DOI: 10.1021/acs.jmedchem.2c00862). Journal of Medicinal Chemistry, 66(11), 7668. https://doi.org/10.1021/acs.jmedchem.3c00892

@article{a74a4d6245b64eb788914b90b36533a0,

title = "Correction: Structure-based design, optimization, and evaluation of potent stabilized peptide inhibitors disrupting MTDH and SND1 interaction (Journal of Medicinal Chemistry (2022) 65:18 (12188-12199) DOI: 10.1021/acs.jmedchem.2c00862)",

abstract = "Page 12198. Instead of The authors declare no competing financial interest , the following Note should be included: The authors declare the following competing financial interest(s): Y.K. is a founder and equity holder of Firebrand Therapeutics, Inc, which is developing inhibitors against MTDH/SND1. Received.",

author = "Hailing Chen and Meimiao Zhan and Jianbo Liu and Zhihong Liu and Minhong Shen and Fenfang Yang and Yibin Kang and Feng Yin and Zigang Li",

year = "2023",

month = jun,

day = "8",

doi = "10.1021/acs.jmedchem.3c00892",

language = "English (US)",

volume = "66",

pages = "7668",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "11",

}

Chen, H, Zhan, M, Liu, J, Liu, Z, Shen, M, Yang, F, Kang, Y, Yin, F & Li, Z 2023, 'Correction: Structure-based design, optimization, and evaluation of potent stabilized peptide inhibitors disrupting MTDH and SND1 interaction (Journal of Medicinal Chemistry (2022) 65:18 (12188-12199) DOI: 10.1021/acs.jmedchem.2c00862)', Journal of Medicinal Chemistry, vol. 66, no. 11, pp. 7668. https://doi.org/10.1021/acs.jmedchem.3c00892

Correction: Structure-based design, optimization, and evaluation of potent stabilized peptide inhibitors disrupting MTDH and SND1 interaction (Journal of Medicinal Chemistry (2022) 65:18 (12188-12199) DOI: 10.1021/acs.jmedchem.2c00862). / Chen, Hailing; Zhan, Meimiao; Liu, Jianbo et al.
In: Journal of Medicinal Chemistry, Vol. 66, No. 11, 08.06.2023, p. 7668.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction

T2 - Structure-based design, optimization, and evaluation of potent stabilized peptide inhibitors disrupting MTDH and SND1 interaction (Journal of Medicinal Chemistry (2022) 65:18 (12188-12199) DOI: 10.1021/acs.jmedchem.2c00862)

AU - Chen, Hailing

AU - Zhan, Meimiao

AU - Liu, Jianbo

AU - Liu, Zhihong

AU - Shen, Minhong

AU - Yang, Fenfang

AU - Kang, Yibin

AU - Yin, Feng

AU - Li, Zigang

PY - 2023/6/8

Y1 - 2023/6/8

N2 - Page 12198. Instead of The authors declare no competing financial interest , the following Note should be included: The authors declare the following competing financial interest(s): Y.K. is a founder and equity holder of Firebrand Therapeutics, Inc, which is developing inhibitors against MTDH/SND1. Received.

AB - Page 12198. Instead of The authors declare no competing financial interest , the following Note should be included: The authors declare the following competing financial interest(s): Y.K. is a founder and equity holder of Firebrand Therapeutics, Inc, which is developing inhibitors against MTDH/SND1. Received.

UR - https://www.scopus.com/pages/publications/85162246829

UR - https://www.scopus.com/inward/citedby.url?scp=85162246829&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.3c00892

DO - 10.1021/acs.jmedchem.3c00892

M3 - Comment/debate

C2 - 37227932

AN - SCOPUS:85162246829

SN - 0022-2623

VL - 66

SP - 7668

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 11

ER -

Chen H, Zhan M, Liu J, Liu Z, Shen M, Yang F et al. Correction: Structure-based design, optimization, and evaluation of potent stabilized peptide inhibitors disrupting MTDH and SND1 interaction (Journal of Medicinal Chemistry (2022) 65:18 (12188-12199) DOI: 10.1021/acs.jmedchem.2c00862). Journal of Medicinal Chemistry. 2023 Jun 8;66(11):7668. doi: 10.1021/acs.jmedchem.3c00892

Correction: Structure-based design, optimization, and evaluation of potent stabilized peptide inhibitors disrupting MTDH and SND1 interaction (Journal of Medicinal Chemistry (2022) 65:18 (12188-12199) DOI: 10.1021/acs.jmedchem.2c00862)

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this